Simplex Trading’s Connect Biopharma Holdings CNTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.5K Buy
8,200
+7,300
+811% +$19K ﹤0.01% 6718
2025
Q4
$2.54K Buy
+900
New +$1.92K ﹤0.01% 7751
2022
Q2
Sell
-800
Closed -$2K 10075
2022
Q1
$2K Hold
800
﹤0.01% 9831
2021
Q4
$4K Buy
+800
New +$8.89K ﹤0.01% 9651

Other funds holding CNTB

Simplex Trading's CNTB Position: Q1 2026 in Review

Simplex Trading sold out of Connect Biopharma Holdings (CNTB) in Q1 2026, closing a stake of 98 shares — an estimated $255 sold.

Simplex Trading first reported a position in CNTB in Q4 2021 and held it in 6 quarters. The position peaked at $42K in Q4 2021. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Simplex Trading reported no remaining Connect Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 98 Connect Biopharma Holdings shares in Q1 2026, an estimated $255.
  • Simplex Trading first reported a position in Connect Biopharma Holdings in Q4 2021 and held it in 6 quarters.
  • Simplex Trading's Connect Biopharma Holdings position peaked at $42K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.